Century Therapeutics

Century Therapeutics is an innovative biotechnology company building an industry-leading, allogeneic, iPSC-derived cell therapy platform that integrates cutting-edge gene editing, protein engineering, technical development and manufacturing capabilities to generate allogeneic, iPSC-derived therapies for autoimmune diseases, including type 1 diabetes, and cancer. The company is headquartered in Philadelphia, United States, and is publicly traded on NASDAQ under the ticker IPSC.

Century Therapeutics is a biotechnology company based in Philadelphia, United States. It is developing allogeneic, iPSC-derived cell therapies for autoimmune diseases, including type 1 diabetes, and cancer. The company is publicly traded on NASDAQ under the ticker IPSC.

1. Home | Century Therapeutics
2. About | Century Therapeutics
3. Century Therapeutics (United States)